Piper Sandler Sticks to Their Buy Rating for Allstate (ALL)
π Piper Sandler analyst Paul Newsome maintains a Buy rating on Allstate (ALL) with a price target of $268.00.
π The company reported Q1 revenue of $16.94 billion and net profit of $2.46 billion, compared to $16.26 billion revenue and $595 million profit last year.
β Newsome is a 5-star analyst with an average return of 11.2% and a 66.46% success rate covering the Financial sector.
π KBW's Meyer Shields also issued a Buy rating on Allstate in a report from May 21.
β οΈ Barclays maintained a Sell rating on Allstate as of May 22, contrasting with other bullish analyst views.
π Corporate insider sentiment is negative based on activity from 94 insiders over the past quarter.
πΈ Insider Mario Rizzo sold 18,578 shares for $4,064,866.40 earlier this month, contributing to increased selling activity.
πͺοΈ Allstate reported estimated catastrophe losses of $870 million for April 2026.
π Other analysts have adjusted price targets, with Keefe Bruyette raising the target to $266 and Mizuho lowering it to $255.
π’ The article notes that Allstate's Q1 margins were strong but offset by slower premium growth in some analyst assessments.
- Piper Sandler maintained a Buy rating on Allstate with a price target of $268.00, signaling strong institutional confidence.
- Allstate reported quarterly revenue of $16.94 billion and net profit of $2.46 billion for the quarter ending March 31, representing significant growth compared to last year's figures.
- Analyst Paul Newsome from Piper Sandler is a 5-star analyst with an average return of 11.2% and a 66.46% success rate, adding credibility to the positive outlook.
- KBW's Meyer Shields also issued a Buy rating on Allstate in a report dated May 21, reinforcing bullish sentiment from multiple analysts.
- Allstate reported April 2026 estimated catastrophe losses of $870M, indicating manageable risk exposure for the upcoming period.
- The company's strong Q1 margins have been highlighted by analysts as a key positive factor offsetting slower premium growth.
- Keefe Bruyette raised Allstate's price target to $266 from $260, reflecting growing analyst optimism about the stock's potential.
- Barclays maintained a Sell rating on Allstate (NYSE: ALL) as of May 22, contrasting with recent Buy ratings from other analysts.
- Corporate insider sentiment is negative due to increased selling activity among 94 insiders over the past quarter.
- Mario Rizzo, an insider at Allstate, sold 18,578 shares for $4,064,866.40 earlier this month.
- Mizuho lowered its price target for Allstate to $255 from $259, indicating analyst concern over the stock's valuation.
- Allstate reported April estimated catastrophe losses of $870M, which could impact future profitability and margins.